Development of spray dried liposomal dry powder inhaler of Dapsone. - Wikidata - awgldk - TriplyDB

Development of spray dried liposomal dry powder inhaler of Dapsone.

Development of spray dried liposomal dry powder inhaler of Dapsone.

http://www.wikidata.org/entity/Q41989747

about

Dry Powder Inhalers: A Focus on Advancements in Novel Drug Delivery Systems Aerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery Systems Aggregated Nanotransfersomal Dry Powder Inhalation of Itraconazole for Pulmonary Drug Delivery.Aerosol Delivery of siRNA to the Lungs. Part 2: Nanocarrier-based Delivery Systems Delivery of antibiotics to the respiratory tract: an update.Stabilization of liposomes during drying.Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery.Hydrogels for controlled pulmonary delivery.Dry powder inhalation: past, present and future.Formulation development and evaluation of hybrid nanocarrier for cancer therapy: Taguchi orthogonal array based design.Development of Novel Chitosan Microcapsules for Pulmonary Delivery of Dapsone: Characterization, Aerosol Performance, and In Vivo Toxicity Evaluation.Effect of cholesterol on the properties of spray-dried lysozyme-loaded liposomal powders.Chapter 9 - Nanoliposomal dry powder formulations.Freeze-dried targeted mannosylated selenium-loaded nanoliposomes: development and evaluation.Nanoemulsion containing dapsone for topical administration: a study of in vitro release and epidermal permeation.Single step bottom-up process to generate solid phospholipid nano-particles.Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance.

P2860

Q28076594-C50D2391-94DE-4B4A-9C20-2A1BA5CD38F7 Q28392004-16146F42-1D3F-4C14-9EF2-AD217334B4BC Q36001570-21A5AA1B-CE75-49D8-8BE4-BC4B2996E849 Q36341433-142ED8B3-3600-4F72-8112-90D365BF36B3 Q37564542-58C0088B-7E1F-4DE8-8EE3-322AC66D8CE7 Q37835823-DD9BDD46-CE5E-4A33-B990-5B3DEDC1C562 Q37978509-ECBC9D83-F6F3-41CC-972C-7C4181A2F71E Q38151737-E9002C7A-F507-4095-A321-EE9C5BBBFF3B Q38830375-77C3CAB8-571F-4A55-8972-945F1CDAB1D6 Q39084192-D29D4E1A-7794-452E-83F6-717E3DDBADCA Q41503040-C3C13D04-ED82-414A-97F1-7F5598E7FA78 Q41948576-7EA79549-7442-4540-99E6-5AC72646370B Q42097420-91C0B132-1B8D-4C38-9C64-D716E77D7D80 Q42574200-9EB39756-242E-47FE-B821-49C8035974A3 Q43247356-36BCBADD-7FE1-4175-80B0-6FB85F642274 Q46724408-A5C72A64-106D-4947-9F73-C6523ADA3440 Q53446106-C96ED47E-370D-49B3-B2E7-C89990B5224D

P2860

Development of spray dried liposomal dry powder inhaler of Dapsone.

http://www.wikidata.org/entity/Q41989747

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Development of spray dried liposomal dry powder inhaler of Dapsone.

@en

type

label

Development of spray dried liposomal dry powder inhaler of Dapsone.

@en

prefLabel

Development of spray dried liposomal dry powder inhaler of Dapsone.

@en

P1433

Q41989747-BDA48B92-7C93-470D-AEA4-090329B73A38

P1476

Q41989747-AC7F5142-C045-4190-AB70-47B1B6898239

P2093

Q41989747-03A0395B-7BDF-4DBE-843F-66143B910574

Q41989747-74908A98-11AD-413A-B36A-A1B920B15386

Q41989747-EF9E798F-F048-4970-BA16-364A8F072074

P2860

Q41989747-1352AECB-0C3D-4498-AC9B-6F738D7D22DA

Q41989747-1C7B763E-6ED3-4E0F-8D25-AE69CFBC6C1E

Q41989747-21E460CE-33F8-45A0-89DB-5FF3CF61D699

Q41989747-3F447ADA-45B9-4E73-A144-96F728F0F966

Q41989747-460604E1-8021-4BE6-B184-8BCED2D58A52

Q41989747-472E10A7-7127-4723-9B18-772869BE6914

Q41989747-5F7A6ABE-196C-41DA-BD79-AD032D389BBF

Q41989747-60D15A0F-E81F-4266-966D-EFDDAEE6A525

Q41989747-64B7A9DA-5E35-4D1C-98CA-1135F7EE194C

Q41989747-78767B95-41E4-45B3-9468-CF5DD37F1439

P2888

Q41989747-6786EC95-7970-49AF-B272-94F46E0A5D15

P304

Q41989747-865A2A72-77DA-4875-9D19-8B9FC7CDEB3C

P31

Q41989747-441157A0-A823-4A20-8299-B41818C23DF9

P356

Q41989747-BF3B9B08-BA20-472D-97B0-36FD58AB2CCC

P407

Q41989747-4FE05DB2-8CC9-4198-8807-4996FF048854

P433

Q41989747-828FF823-6726-4E2E-8374-303E2D992D99

P478

Q41989747-9A6A46DB-2F11-4AB7-888B-1F2221E5CD50

P577

Q41989747-9884F42F-5B0A-42E8-96E8-EF0537B61783

P5875

Q41989747-A668614C-BAAC-43D4-9667-35CD5E2CA40E

P6179

Q41989747-4AC316F6-86FF-4E35-905C-0022F172EAEA

P698

Q41989747-94A65805-963D-497D-AAE9-98FA2BB64879

P932

Q41989747-47CA0042-E958-41DE-9829-3D452B87EB11

P356

S12249-007-9024-6

P1433

AAPS PharmSciTech

P1476

Development of spray dried liposomal dry powder inhaler of Dapsone.

@en

P2093

Ambikanandan Misra

http://www.w3.org/2001/XMLSchema#string

Bijay Padhi

http://www.w3.org/2001/XMLSchema#string

Mahavir Chougule

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of infection due to Pneumocystis carinii

Droplet and particle size relationship and shell thickness of inhalable lactose particles during spray drying.

Human immunodeficiency virus and respiratory infection.

Trojan particles: large porous carriers of nanoparticles for drug delivery.

Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis.

Pneumocystis carinii pneumonia prophylaxis in HIV negative patients with primary CNS lymphoma.

Liposomal dry powders as aerosols for pulmonary delivery of proteins

Pulmonary infectious complications of human immunodeficiency virus infection. Part I.

The effect of adjunctive corticosteroids for the treatment of Pneumocystis carinii pneumonia on mortality and subsequent complications.

Nano-liposomal dry powder inhaler of tacrolimus: preparation, characterization, and pulmonary pharmacokinetics.

P2888

s12249-007-9024-6

P304

47-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1208/S12249-007-9024-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5406899

http://www.w3.org/2001/XMLSchema#string

P6179

1019187367

http://www.w3.org/2001/XMLSchema#string

P698

18446460

http://www.w3.org/2001/XMLSchema#string

P932

2976880

http://www.w3.org/2001/XMLSchema#string